title: Concerning the Article by Fung et al, Titled "Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
authors.affiliation: Department of Endocrinology, Ghent University Hospital, Ghent, Belgium. Electronic address: Justine.defreyne@ugent.be.
authors.forename: Justine
authors.initials: J
authors.lastname: Defreyne
authors.affiliation: Department of Endocrinology, Ghent University Hospital, Ghent, Belgium; Center for Sexology and Gender, Ghent University Hospital, Ghent, Belgium.
authors.forename: Guy
authors.initials: G
authors.lastname: T'Sjoen
mesh_terms: D000726:Androgen Antagonists; D003534:Cyproterone; D017373:Cyproterone Acetate; D004997:Ethinyl Estradiol; D005260:Female; D006801:Humans; D008075:Lipoproteins, HDL; D011388:Prolactin / Q000097:blood*; D013148:Spironolactone; D063106:Transgender Persons; D008297:Male
chemical_list: D000726:Androgen Antagonists; D008075:Lipoproteins, HDL; D013148:Spironolactone; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; D011388:Prolactin; D003534:Cyproterone